JP2024534041A5 - - Google Patents
Info
- Publication number
- JP2024534041A5 JP2024534041A5 JP2024509040A JP2024509040A JP2024534041A5 JP 2024534041 A5 JP2024534041 A5 JP 2024534041A5 JP 2024509040 A JP2024509040 A JP 2024509040A JP 2024509040 A JP2024509040 A JP 2024509040A JP 2024534041 A5 JP2024534041 A5 JP 2024534041A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variant polypeptide
- composition according
- igg
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233511P | 2021-08-16 | 2021-08-16 | |
| US63/233,511 | 2021-08-16 | ||
| PCT/US2022/075002 WO2023023503A1 (en) | 2021-08-16 | 2022-08-16 | Interleukin-12 variants and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534041A JP2024534041A (ja) | 2024-09-18 |
| JP2024534041A5 true JP2024534041A5 (https=) | 2025-08-20 |
Family
ID=85239804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509040A Pending JP2024534041A (ja) | 2021-08-16 | 2022-08-16 | インターロイキン－１２バリアント及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240342246A1 (https=) |
| EP (1) | EP4387989A4 (https=) |
| JP (1) | JP2024534041A (https=) |
| CN (1) | CN118510794A (https=) |
| AU (1) | AU2022331610A1 (https=) |
| CA (1) | CA3229251A1 (https=) |
| IL (1) | IL310868A (https=) |
| WO (1) | WO2023023503A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121152798A (zh) * | 2023-05-12 | 2025-12-16 | 新叶生维(英国)有限公司 | 分泌特异性降效细胞因子il-12的car t细胞 |
| WO2025012105A2 (en) | 2023-07-07 | 2025-01-16 | Technische Universitaet Muenchen, In Vertretung Des Freistaates Bayern | Muteins of human interleukin 12 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503258A (ja) * | 1996-10-18 | 2001-03-13 | バレンティス・インコーポレーテッド | 遺伝子発現および搬送系および用途 |
| US7083784B2 (en) * | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| BRPI0818287A2 (pt) * | 2007-10-08 | 2015-11-03 | Intrexon Corp | células dendríticas manipuladas e usos para o tratamento do câncer. |
| US20200095323A1 (en) * | 2017-03-20 | 2020-03-26 | The General Hospital Corporation | MITIGATING Fc-Fc RECEPTOR INTERACTIONS IN CANCER IMMUNOTHERAPY |
| TW202132342A (zh) * | 2019-11-26 | 2021-09-01 | 大陸商北京軒義醫藥科技有限公司 | T細胞活性的調節劑 |
-
2022
- 2022-08-16 AU AU2022331610A patent/AU2022331610A1/en active Pending
- 2022-08-16 CA CA3229251A patent/CA3229251A1/en active Pending
- 2022-08-16 EP EP22859313.3A patent/EP4387989A4/en active Pending
- 2022-08-16 WO PCT/US2022/075002 patent/WO2023023503A1/en not_active Ceased
- 2022-08-16 JP JP2024509040A patent/JP2024534041A/ja active Pending
- 2022-08-16 US US18/683,398 patent/US20240342246A1/en active Pending
- 2022-08-16 CN CN202280069536.1A patent/CN118510794A/zh active Pending
- 2022-08-16 IL IL310868A patent/IL310868A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8455625B2 (en) | Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 | |
| CN104245734B (zh) | 靶向突变体α‑螺旋束细胞因子 | |
| JP7728635B2 (ja) | シンセカイン組成物及び使用方法 | |
| Stumpp et al. | DARPins: a new generation of protein therapeutics | |
| JP4516718B2 (ja) | 組換えエリスロポエチンと部分的に組合されたｉｌ−１インヒビターおよびｔｎｆアンタゴニストの貧血治療用途 | |
| ES2356896T3 (es) | Anticuerpos humanizados contra icam-1, su producción y usos. | |
| JP2021521822A5 (https=) | ||
| JP2022511135A (ja) | アルブミン結合ドメイン融合タンパク質 | |
| JP2024534041A5 (https=) | ||
| JP2019506843A5 (https=) | ||
| JP2017529059A5 (https=) | ||
| JP2011525363A5 (https=) | ||
| ME00238B (me) | Mimičko vezivanje dimernog trombopoitetinskog peptida za mp1 receptor sa trombopoietičkom aktivnošću | |
| ES2750730T3 (es) | Dímero de G-CSF humano recombinante y uso del mismo para el tratamiento de enfermedades neurológicas | |
| JP2004508828A (ja) | 標的−特異的プロドラッグとしての使用のための抗体サイトカイン−サイトカインインヒビター（セレクトカイン）からの融合タンパク質 | |
| Weidle et al. | Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon | |
| ES2241040T3 (es) | Proteinas hibridas que forman heterodimeros. | |
| JP2008521426A5 (https=) | ||
| ES2267294T3 (es) | Reversion del choque generalizado inducido por virus y de la disnea mediante el bloqueo de la ruta de la linfotoxina beta. | |
| ES2355488T3 (es) | Proteína de fusión de tranferrina modificadas. | |
| ITFI20090006A1 (it) | Processo per la produzione di proteine di fusione polivalenti e polispecifiche utilizzando come struttura portante l'uteroglobina e prodotti cosi' ottenuti. | |
| CN102574907B (zh) | 修饰的人肿瘤坏死因子受体i多肽或其片段以及制备它们的方法 | |
| ES2236696T3 (es) | Proteina de union de interferon-alfa/beta, su preparacion y su uso. | |
| WO2005024027A1 (ja) | 抗体医薬 | |
| WO2022056493A1 (en) | Biomarker driven methods for treating major depressive disorder |